Newsroom | 2596 results
Sorted by: Latest
-
Longhorn Vaccines and Diagnostics Partners with Promega to Combine Complementary Offerings for Enhanced Sample Collection, Transport and Analysis
BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced a strategic co-marketing agreement with Promega Corporation to deliver integrated molecular testing solutions designed to enhance safety, efficiency and flexibility across a wide range of diagnostic settings. This collaboration brings together Longhorn’s validated PrimeStore® Molecular...
-
Tractive Acquires Whistle from Mars Petcare to Accelerate Leadership in Global Pet Tech Market
PASCHING, Austria & SEATTLE--(BUSINESS WIRE)--Strategic Acquisition Expands U.S. Market Presence and Brings Advanced Wellness Technology to Global Pet Parent Community...
-
Colgate Women's Games Teams Up with World-Class Athletes Sha'Carri Richardson, Ajeé Wilson and Natasha Hastings for Milestone 50th Season
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company announced today that Colgate Women’s Games, the nation’s longest-running indoor Track & Field series for girls and women, will return this December with Sha'Carri Richardson, Ajeé Wilson and Natasha Hastings supporting its 50th anniversary. The 50th Season will run from December 2025 to February 2026, with events taking place at The Nike Track & Field Center at The Armory in New York City. “Track and field didn’t just teach me how to...
-
FCPT Announces Acquisition of an Ethos Veterinary Health Property for $3.7 Million
MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of an Ethos Veterinary Health property for $3.7 million. Ethos Veterinary Health is a network of over 140 specialty and emergency veterinary hospitals across North America. The property is located in a strong re...
-
Airbyte Continues Momentum: Recognized by CRN and G2, Helps Petvisor Realize Higher Performance Managing Complex Data Integrations
SAN FRANCISCO--(BUSINESS WIRE)--Airbyte is a finalist for CRN Tech Innovators Awards, earned High Performer and Momentum Leader in G2 user ratings, adds ClickHouse destination...
-
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the inclusion of veterinary pathogens in its Global Disease Atlas, tackling head-on one of global health’s most pressing challenges: safeguarding protein supply chains, which remain exposed to both endemic and emerging biological diseases. These threats directly undermine the resilience of food syst...
-
Terravet Real Estate Solutions Acquires Nearly $5 Million Former Brewery for BluePearl Pet Hospital in Seattle Metro
BALA CYNWYD, Pa.--(BUSINESS WIRE)--Terravet completed the $4.8 million acquisition and conversion of a former brewery in Tukwila, WA, in partnership with BluePearl Pet Hospital Renton....
-
PBI-Gordon Companies, Inc. Calls on Petspan to Cease and Desist False and Misleading Advertisement, Promotion and Sale of Compounded Rapamycin (Sirolimus) for HCM in Cats
SHAWNEE, Kan.--(BUSINESS WIRE)--PBI-Gordon Companies, Inc. the parent company of TriviumVet, which holds sole conditional new animal drug approval from the FDA for Felycin®-CA1 (sirolimus delayed-release tablets) under its affiliated brand company Pegasus, through its outside counsel issued a cease-and-desist demand letter to Petspan for falsely promoting a compounded version of rapamycin (synonymous with sirolimus) for the treatment and management of clinical hypertrophic cardiomyopathy (HCM)...
-
Weave Now Integrates with Neo
LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience software platform for small and medium-sized healthcare businesses, today announced an integration with Neo, a leading cloud-based veterinary practice management software. This integration allows veterinarians to better manage their business through automation and optimization of tasks by unlocking the following Weave features: Appointment Reminders and Confirmation Writebacks: Weave sends automated appoin...
-
Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate’s website at https://investor...